Use of hormonal contraceptives and risk of <font color="blue">HIV-1_1</font> transmission : a prospective cohort study . 
<br>
<br> BACKGROUND Hormonal contraceptives are used widely but their effects on HIV-1 risk are unclear . We aimed to assess the association between hormonal contraceptive use and risk of <font color="blue">HIV-1_1</font> <font color="blue">acquisition_1</font> <font color="blue">by_1</font> <font color="blue">women_1</font> <font color="blue">and_1</font> <font color="blue">HIV-1_1</font> <font color="blue">transmission_1</font> <font color="blue">from_1</font> <font color="blue">HIV-1-infected_1</font> <font color="blue">women_1</font> <font color="blue">to_1</font> <font color="blue">their_1</font> <font color="blue">male_1</font> <font color="blue">partners_1</font> <font color="blue">._1</font> 
<br> METHODS In this prospective study , <font color="blue">we_1</font> <font color="blue">followed_1</font> <font color="blue">up_1</font> <font color="blue">3790_5</font> <font color="blue">heterosexual_5</font> <font color="blue">HIV-1-serodiscordant_5</font> <font color="blue">couples_5</font> <font color="blue">participating_5</font> <font color="blue">in_5</font> <font color="blue">two_5</font> <font color="blue">longitudinal_5</font> <font color="blue">studies_5</font> <font color="blue">of_5</font> <font color="blue">HIV-1_5</font> <font color="blue">incidence_5</font> <font color="blue">in_5</font> <font color="blue">seven_5</font> <font color="blue">African_5</font> <font color="blue">countries_5</font> <font color="blue">._5</font> Among injectable and oral hormonal contraceptive users and non - users , we compared rates of HIV-1 acquisition by women and HIV-1 transmission from women to men . The primary outcome measure was HIV-1 seroconversion . We used Cox <font color="blue">proportional_1</font> <font color="blue">hazards_1</font> <font color="blue">regression_1</font> <font color="blue">and_1</font> <font color="blue">marginal_1</font> <font color="blue">structural_1</font> <font color="blue">modelling_1</font> <font color="blue">to_1</font> <font color="blue">assess_1</font> <font color="blue">the_1</font> <font color="blue">effect_1</font> <font color="blue">of_1</font> <font color="blue">contraceptive_1</font> <font color="blue">use_1</font> <font color="blue">on_1</font> <font color="blue">HIV-1_1</font> <font color="blue">risk_1</font> <font color="blue">._1</font> <font color="blue">
<br>_1</font> <font color="blue">FINDINGS_1</font> <font color="blue">Among_1</font> <font color="blue">1314_4</font> <font color="blue">couples_4</font> <font color="blue">in_4</font> <font color="blue">which_4</font> <font color="blue">the_4</font> <font color="blue">HIV-1-seronegative_4</font> <font color="blue">partner_4</font> <font color="blue">was_4</font> <font color="blue">female_4</font> <font color="blue">(_3</font> <font color="blue">median_3</font> <font color="blue">follow_3</font> <font color="blue">-_3</font> <font color="blue">up_3</font> <font color="blue">18·0_3</font> <font color="blue">[_3</font> <font color="blue">IQR_3</font> <font color="blue">12·6_3</font> <font color="blue">-_3</font> <font color="blue">24·2_3</font> <font color="blue">]_3</font> <font color="blue">months_3</font> <font color="blue">)_3</font> <font color="blue">,_3</font> <font color="blue">rates_2</font> <font color="blue">of_2</font> <font color="blue">HIV-1_2</font> <font color="blue">acquisition_2</font> <font color="blue">were_2</font> <font color="blue">6·61_2</font> <font color="blue">per_2</font> <font color="blue">100_2</font> <font color="blue">person_2</font> <font color="blue">-_2</font> <font color="blue">years_2</font> <font color="blue">in_2</font> <font color="blue">women_2</font> <font color="blue">who_2</font> <font color="blue">used_2</font> <font color="blue">hormonal_2</font> <font color="blue">contraception_2</font> <font color="blue">and_2</font> <font color="blue">3·78_2</font> <font color="blue">per_2</font> <font color="blue">100_2</font> <font color="blue">person_2</font> <font color="blue">-_2</font> <font color="blue">years_2</font> <font color="blue">in_2</font> <font color="blue">those_2</font> <font color="blue">who_2</font> <font color="blue">did_2</font> <font color="blue">not_2</font> <font color="blue">(_2</font> <font color="blue">adjusted_2</font> <font color="blue">hazard_2</font> <font color="blue">ratio_2</font> <font color="blue">1·98_2</font> <font color="blue">,_2</font> <font color="blue">95%_2</font> <font color="blue">CI_2</font> <font color="blue">1·06_2</font> <font color="blue">-_2</font> <font color="blue">3·68_2</font> <font color="blue">,_2</font> <font color="blue">p=0·03_2</font> <font color="blue">)_2</font> . Among <font color="blue">2476_2</font> <font color="blue">couples_2</font> <font color="blue">in_2</font> <font color="blue">which_2</font> <font color="blue">the_2</font> <font color="blue">HIV-1-seronegative_2</font> <font color="blue">partner_2</font> <font color="blue">was_2</font> <font color="blue">male_2</font> <font color="blue">(_1</font> <font color="blue">median_1</font> <font color="blue">follow_1</font> <font color="blue">-_1</font> <font color="blue">up_1</font> <font color="blue">18·7_1</font> <font color="blue">[_1</font> <font color="blue">IQR_1</font> <font color="blue">12·8_1</font> <font color="blue">-_1</font> <font color="blue">24·2_1</font> <font color="blue">]_1</font> <font color="blue">months_1</font> <font color="blue">)_1</font> <font color="blue">,_1</font> <font color="blue">rates_1</font> <font color="blue">of_1</font> <font color="blue">HIV-1_1</font> <font color="blue">transmission_1</font> <font color="blue">from_1</font> <font color="blue">women_1</font> <font color="blue">to_1</font> <font color="blue">men_1</font> <font color="blue">were_1</font> <font color="blue">2·61_1</font> <font color="blue">per_1</font> <font color="blue">100_1</font> <font color="blue">person_1</font> <font color="blue">-_1</font> <font color="blue">years_1</font> <font color="blue">in_1</font> <font color="blue">couples_1</font> <font color="blue">in_1</font> <font color="blue">which_1</font> <font color="blue">women_1</font> <font color="blue">used_1</font> <font color="blue">hormonal_1</font> <font color="blue">contraception_1</font> <font color="blue">and_1</font> <font color="blue">1·51_1</font> <font color="blue">per_1</font> <font color="blue">100_1</font> <font color="blue">person_1</font> <font color="blue">-_1</font> <font color="blue">years_1</font> <font color="blue">in_1</font> <font color="blue">couples_1</font> <font color="blue">in_1</font> <font color="blue">which_1</font> <font color="blue">women_1</font> <font color="blue">did_1</font> <font color="blue">not_1</font> <font color="blue">use_1</font> <font color="blue">hormonal_1</font> <font color="blue">contraception_1</font> <font color="blue">(_1</font> <font color="blue">adjusted_1</font> <font color="blue">hazard_1</font> <font color="blue">ratio_1</font> <font color="blue">1·97_1</font> <font color="blue">,_1</font> <font color="blue">95%_1</font> <font color="blue">CI_1</font> <font color="blue">1·12_1</font> <font color="blue">-_1</font> <font color="blue">3·45_1</font> <font color="blue">,_1</font> <font color="blue">p=0·02_1</font> <font color="blue">)_1</font> <font color="blue">._1</font> Marginal structural model analyses generated much the same results to the Cox proportional hazards regression . 
<br> INTERPRETATION Women should be counselled about potentially increased risk of HIV-1 acquisition and transmission with hormonal contraception , especially injectable methods , and about the importance of dual protection with condoms to decrease HIV-1 risk . Non - hormonal or low - dose hormonal contraceptive methods should be considered for women with or at - risk for HIV-1 . 
<br> FUNDING US National Institutes of Health and the Bill & Melinda Gates Foundation .